CHU Grenoble Alpes
Grenoble, 38043, France
NCT Number: NCT03903341
This pilot study aims at investigating the role of superior colliculus in patients with idiopathic blepharospasm (BSP) de novo, compared to healthy subjects.
Looking for future studies?
Notify Me30 year–70 year
All sexes
Interventional
Not applicable
Grenoble, 38043, France
The objective of the study is to investigate the function of the superior colliculus (SC) related to visual stimulation by means of fMRI (functional magnetic resonance imaging) in patients with idiopathic BSP compared to healthy subjects. The hypothesis is that SC function is impaired in BSP (role of biomarker of SC).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
bold signal in visual pathway
Time frame: In a five months period after inclusion
To measure the bold signal in superior colliculus and lateral geniculate corpus
University Hospital, Grenoble
Other
The Role of the Upper Colliculus in the Idiopathic Blepharospasm : a Pilot Study in Functional MRI
Acronym: COLL-BSP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04423341
Benign essential blepharospasm, Blepharospasm
Oakland, California, United States
View Trial DetailsNCT07489430
Basal Ganglia Diseases, Benign essential blepharospasm
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT02370875
Benign Essential Blepharospasm, Benign essential blepharospasm
Gainesville, Florida, United States
View Trial DetailsNCT03641950
Benign essential blepharospasm, Essential Blepharospasm
Seoul, Korea, South Korea
View Trial Details